Methylglyoxal inhibits glycation-mediated loss in chaperone function and synthesis of pentosidine in α-crystallin

Experimental Eye Research

Volumn 84, Issue 5, 2007, Pages 914-921

  Puttaiah, Shivaprakash ^a   Biswas, Ashis ^b   Staniszewska, Magdalena ^a   Nagaraj, Ram H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

argpyrimidine; chaperone; human lens; methylglyoxal; pentosidine

Indexed keywords

ALPHA CRYSTALLIN; ASCORBIC ACID; CARBOHYDRATE DERIVATIVE; CHAPERONE; METHYLGLYOXAL; PENTOSIDINE;

AGING; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; LENS; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; RAT;

ALPHA-CRYSTALLINS; ANIMALS; ARGININE; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE PROTEINS; GLYCOSYLATION; LENS, CRYSTALLINE; LYSINE; MOLECULAR CHAPERONES; ORGAN CULTURE TECHNIQUES; PYRUVALDEHYDE; RATS;

EID: 34247153034     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.01.013     Document Type: Article

References (40)

1. Ahmed N., Dobler D., Dean M., and Thornalley P.J. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J. Biol. Chem. 280 (2005) 5724-5732
2. Ahmed N., Thornalley P.J., Dawczynski J., Franke S., Strobel J., Stein G., and Haik G.M. Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5287-5292
3. Biemel K.M., Friedl D.A., and Lederer M.O. Identification and quantification of major Maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J. Biol. Chem. 277 (2002) 24907-24915
4. Biemel K.M., Reihl O., Conrad J., and Lederer M.O. Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor. J. Biol. Chem. 276 (2001) 23405-23412
5. Biswas A., Miller A., Oya-Ito T., Santhoshkumar P., Bhat M., and Nagaraj R.H. Effect of site-directed mutagenesis of methylglyoxal-modifiable arginine residues on the structure and chaperone function of human α-crystallin. Biochemistry 45 (2006) 4569-4577
6. Chellan P., and Nagaraj R.H. Protein cross-linking by the Maillard reaction: dicarbonyl-derived imidazolium cross-links in aging and diabetes. Arch. Biochem. Biophys. 368 (1999) 98-104
7. Cheng R., Feng Q., Argirov O.K., and Ortwerth B.J. Structure elucidation of a novel yellow chromophore from human lens protein. J. Biol. Chem. 279 (2004) 45441-45449
8. Cheng R., Feng Q., and Ortwerth B.J. LC-MS display of the total modified amino acids in cataract lens proteins and in lens proteins glycated by ascorbic acid in vitro. Biochim. Biophys. Acta 1762 (2006) 533-543
9. Cheng R., Lin B., Lee K.W., and Ortwerth B.J. Similarity of the yellow chromophores isolated from human cataracts with those from ascorbic acid-modified calf lens proteins: evidence for ascorbic acid glycation during cataract formation. Biochim. Biophys. Acta 1537 (2001) 14-26
10. Cherian M., and Abraham E.C. Decreased molecular chaperone property of α-crystallins due to posttranslational modifications. Biochem. Biophys. Res. Commun. 208 (1995) 675-679
11. Dunn J.A., Patrick J.S., Thorpe S.R., and Baynes J.W. Oxidation of glycated proteins: age-dependent accumulation of N-epsilon-(carboxymethyl)lysine in lens proteins. Biochemistry 28 (1989) 9464-9468
12. Grandhee S.K., and Monnier V.M. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J. Biol. Chem. 266 (1991) 11649-11653
13. Haik Jr. G.M., Lo T.W., and Thornalley P.J. Methylglyoxal concentration and glyoxalase activities in the human lens. Exp. Eye Res. 59 (1994) 497-500
14. Hashimoto H., Arai K., Yoshida S., Chikuda M., and Obara Y. Pentosidine and autofluorescence in lenses of diabetic patients. Jpn. J. Ophthalmol. 41 (1997) 274-277
15. Horwitz J. α-Crystallin. Exp. Eye Res. 76 (2003) 145-153
16. Kumar M.S., Reddy P.Y., Kumar P.A., Surolia I., and Reddy G.B. Effect of dicarbonyl-induced browning on α-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays. Biochem. J. 379 (2004) 273-282
17. Lo T.W., Westwood M.E., McLellan A.C., Selwood T., and Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N-α-acetylarginine, N-α-acetylcysteine, and N-α-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269 (1994) 32299-32305
18. Lohmann W. Ascorbic acid and cataract. Ann. N.Y. Acad. Sci. 498 (1987) 307-311
19. Lyons T.J., Silvestri G., Dunn J.A., Dyer D.G., and Baynes J.W. Role of glycation in modification of lens crystallins in diabetic and non-diabetic senile cataracts. Diabetes 40 (1991) 1010-1015
20. Nagaraj R.H., and Monnier V.M. Isolation and characterization of a blue fluorophore from human eye lens crystallins: in vitro formation from Maillard reaction with ascorbate and ribose. Biochim. Biophys. Acta 1116 (1992) 34-42
21. Nagaraj R.H., Oya-Ito T., Padayatti P.S., Kumar R., Mehta S., West K., Levison B., Sun J., Crabb J.W., and Padival A.K. Enhancement of chaperone function of α-crystallin by methylglyoxal modification. Biochemistry 42 (2003) 10746-10755
22. Nagaraj R.H., Prabhakaram M., Ortwerth B.J., and Monnier V.M. Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase. Diabetes 43 (1994) 580-586
23. Nagaraj R.H., and Sady C. The presence of a glucose-derived Maillard reaction product in the human lens. FEBS Lett. 382 (1996) 234-238
24. Nagaraj R.H., Sell D.R., Prabhakaram M., Ortwerth B.J., and Monnier V.M. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc. Natl. Acad. Sci. USA. 88 (1991) 10257-10261
25. Oya T., Hattori N., Mizuno Y., Miyata S., Maeda S., Osawa T., and Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274 (1999) 18492-18502
26. Padayatti P.S., Ng A.S., Uchida K., Glomb M.A., and Nagaraj R.H. Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1299-1304
27. Phillips S.A., Mirrlees D., and Thornalley P.J. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil. Biochem. Pharmacol. 46 (1993) 805-811
28. Sell D.R., Lane M.A., Johnson W.A., Masoro E.J., Mock O.B., Reiser K.M., Fogarty J.F., Cutler R.G., Ingram D.K., Roth G.S., and Monnier V.M. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc. Natl. Acad. Sci. USA. 93 (1996) 485-490
29. Shamsi F.A., Sharkey E., Creighton D., and Nagaraj R.H. Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens. Exp. Eye Res. 70 (2000) 369-380
30. Sharma K.K., Kaur H., and Kester K. Functional elements in molecular chaperone α-crystallin: identification of binding sites in α B-crystallin. Biochem. Biophys. Res. Commun. 239 (1997) 217-222
31. Shipanova I.N., Glomb M.A., and Nagaraj R.H. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys. 344 (1997) 29-36
32. Staniszewska M.M., and Nagaraj R.H. 3-Hydroxykynurenine-mediated modification of human lens proteins: structure determination of a major modification using a monoclonal antibody. J. Biol. Chem. 280 (2005) 22154-22164
33. Tessier F., Obrenovich M., and Monnier V.M. Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. J. Biol. Chem. 274 (1999) 20796-20804
34. Thornalley P.J. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification: a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 27 (1996) 565-573
35. Thornalley P.J. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem. Biol. Interact. 111-112 (1998) 137-151
36. Thorpe S.R., and Baynes J.W. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25 (2003) 275-281
37. Van Boekel M.A., Hoogakker S.E., Harding J.J., and de Jong W.W. The influence of some post-translational modifications on the chaperone-like activity of α-crystallin. Ophthalmic Res. 28 Suppl 1 (1996) 32-38
38. Vander Jagt D.L., and Hunsaker L.A. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem. Biol. Interact. 143-144 (2003) 341-351
39. Vazquez S., Aquilina J.A., Jamie J.F., Sheil M.M., and Truscott R.J. Novel protein modification by kynurenine in human lenses. J. Biol. Chem. 277 (2002) 4867-4873
40. Wilker S.C., Chellan P., Arnold B.M., and Nagaraj R.H. Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine. Anal. Biochem. 290 (2001) 353-358